(April 9, 2026)

While nuclear fusion is often discussed as a future source of clean energy, companies like SHINE Technologies, based in Janesville, WI, are currently using its power to solve a critical shortage in medical imaging.
(…)
Tc-99m supports about 56,000 patient studies daily in the U.S., helping physicians detect heart disease, cancer, and other serious conditions.
(…)
SHINE announced it has received a conditional commitment for a loan of $263 million from the U.S. Department of Energy’s (DOE) Office of Energy Dominance Financing (EDF). If approved, the financing will support the completion of Chrysalis, a first-of-a-kind medical isotope production facility that will establish the first domestic commercial supply of molybdenum-99 (Mo-99).